Tenax Therapeutics Inc (TENX) Stock Analysis

Tenax Therapeutics Inc (TENX) is a publicly traded company in the HEALTHCARE sector. It trades at $10.95, carries a market capitalization of $314.85M. This page summarizes the public market data, fundamentals, and frequently asked questions for TENX, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Tenax Therapeutics Inc currently has a Bullish sentiment score of 0.23.

About Tenax Therapeutics Inc

Tenax Therapeutics, Inc. is a specialty pharmaceutical company based in Morrisville, North Carolina, dedicated to developing innovative therapies for cardiovascular and pulmonary diseases in the U.S. and Canadian markets. The company focuses on addressing significant unmet medical needs through its proprietary drug development pipeline, highlighting products designed to enhance patient outcomes in critical care environments. With a strong commitment to advancing treatment options in these vit...

GNG Research Analysis

GNG Research scores Tenax Therapeutics Inc (TENX) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for TENX.

Frequently Asked Questions

Does TENX pay dividends?

Tenax Therapeutics Inc (TENX) does not currently pay a regular dividend.

What is TENX's market cap?

Tenax Therapeutics Inc (TENX) has a market capitalization of $314.85M with a current stock price of $10.95.